Table 4. Adverse events reported during the study.

	FMI group	HMI group	Control group	P*
Any adverse event	17 (33.3%)	20 (39.2%)	12 (24.0%)	0.26
Upper respiratory infection	6 (11.8%)	4 (7.8%)	5 (10.0%)	0.80
Musculoskeletal pain	3 (5.9%)	5 (9.8%)	2 (4.0%)	0.49
Dizziness	2 (3.9%)	2 (3.9%)	2 (4.0%)	1.00
Contusion	4 (7.8%)	1 (2.0%)	0 (0.0%)	0.07
Dyspepsia	2 (3.9%)	2 (3.9%)	1 (2.0%)	0.82
Fracture	1 (2.0%)	1 (2.0%)	2 (4.0%)	0.76
Diarrhea	2 (3.9%)	2 (3.9%)	0 (0.0%)	0.37
Ligament injury	2 (3.9%)	1 (2.0%)	1 (2.0%)	0.78
Fall	2 (3.9%)	1 (2.0%)	0 (0.0%)	0.37

Values are shown as numbers (%). FMI, facility-based multidomain intervention; HMI, home-based multidomain intervention. *Chi-square test.